InvestorsHub Logo

CrashOverride

06/17/22 9:50 AM

#487710 RE: vator #487689

Why would we benefit from being bought by a BP that isn't specialized in oncology? No, we would get the best offer by a firm that would have the greatest synergy with DCVax. That's not AZ or really any firm before the trial data was known.